利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.015 秒)

    MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF
    1.
    发明申请
    MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF 有权
    CANNABINOID化合物的混合物，以及其生产和使用

    公开(公告)号：US20150336874A1

    公开(公告)日：2015-11-26

    申请号：US14653044

    申请日：2014-06-30

    申请人： SYMRISE AG

    发明人： Oskar Koch ,  Marcus Rudolf Götz ,  Jan Looft ,  Tobias Vössing

    IPC分类号： C07C69/94 ,  C07C37/50 ,  C07C67/29 ,  A61K31/235 ,  A61K31/05

    CPC分类号： C07C69/94 ,  A61K31/05 ,  A61K31/235 ,  A61K31/352 ,  C07C37/50 ,  C07C67/29 ,  C07C2601/16 ,  A61K2300/00

    摘要： Specific compositions comprising one or multiple (cannabinoid) compound(s) of formula (A) and/or one or multiple salt(s) thereof are described as well as methods for their manufacture. A compound of formula (A), a salt of formula (A) and a respective composition for use as medicine and for use in a method for the therapeutic treatment of the human or animal body, respectively, are also described.Furthermore, corresponding pharmaceutical formulations, cosmetic preparations and foodstuff and/or gourmet or snack preparations fit for consumption as well as a method for the manufacture of delta-9-tetrahydrocannabinol are described.

    摘要翻译： 描述了包含一种或多种（大麻素）式（A）化合物和/或其一种或多种盐的特定组合物及其制备方法。 还描述了式（A）的化合物，式（A）的盐和分别用作药物和用于人体或动物体的治疗方法的各自的组合物。 此外，描述适合消费的相应的药物制剂，化妆品制剂和食品和/或美食或零食制剂以及制造δ-9-四氢大麻酚的方法。

    Probiotics for altering the composition of oral biofilms
    2.
    发明授权
    Probiotics for altering the composition of oral biofilms 有权

    公开(公告)号：US11198848B2

    公开(公告)日：2021-12-14

    申请号：US16070573

    申请日：2017-01-18

    申请人： SYMRISE AG ,  PROBI AB

    发明人： William Wade ,  Marcus Rudolf Götz ,  Manuel Pesaro

    IPC分类号： A61K35/747 ,  C12N1/20 ,  A61K9/00 ,  A61K9/68 ,  A61Q11/00 ,  A61K35/00 ,  C12R1/225

    摘要： The present invention relates to a certain microorganism for altering the composition of oral biofilms, in particular for use in the treatment and/or prevention of dental caries and/or periodontal disease.
    In particular, the present invention relates to a microorganism for use as a probiotic agent for altering the bacterial composition of oral biofilms derived from saliva, preferably for reducing the proportions of Gram-negative anaerobic genera and/or increasing the proportions of aerobic or facultatively anaerobic genera.
    Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising the microorganism as probiotic agents as well as a method of production thereof.

    Probiotics for aggregation with disease-associated species in the oral cavity
    8.
    发明授权
    Probiotics for aggregation with disease-associated species in the oral cavity 有权

    公开(公告)号：US11338001B2

    公开(公告)日：2022-05-24

    申请号：US16478514

    申请日：2018-01-17

    申请人： SYMRISE AG ,  PROBI AB

    发明人： Marcus Rudolf Götz ,  Kerstin Holmgren ,  Niklas Larsson ,  Bernd Fiebich ,  William Wade

    IPC分类号： A61K35/747 ,  A61K9/00

    摘要： The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, preferably for the treatment and/or prevention of gingivitis and/or peridontitis.
    In particular, the present invention relates to microorganisms or mixtures thereof for use as probiotic agents for forming co-aggregates with microorganisms associated with gingivitis and/or peridontitis.
    Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the probiotic microorganisms as active agents as well as a method of production thereof.